20 June 2023>: Original Paper
Survival Analysis of Transplant-Associated Thrombotic Microangiopathy Under Different Diagnostic Criteria and Efficacy of Plasma Exchange
Yifan Xu 12ABCDEF , Yan Wei 12BF , Lijun Wang 2BC , Ning Lu 2BD , Yongli Wu 2BD , Liping Dou 2AF , Daihong Liu 2AF , Meng Li 2ADEF* , Chunji Gao 2ADEFG*DOI: 10.12659/AOT.939890
Ann Transplant 2023; 28:e939890
Table 4 Multivariable analyses affecting the overall survival of TA-TMA patients.
Variable | P value | HR | 95% CI |
---|---|---|---|
III–IV aGVHD prior to TA-TMA | 0.002 | 17.03 | 2.76–105.29 |
Renal or neurological dysfunction | 0.021 | 7.40 | 1.30–40.80 |
Onset of TA-TMA diagnosis, median day post-HSCT | 0.002 | 1.02 | 1.00–1.03 |
aGVHD – acute graft-versus-host disease; PE – plasma exchange. |